CD47 and neoplasm: However, the summed tumor area was 1.8‐fold reduced in CD47 mAb‐treated mice (P = 0.01) and 5‐fold reduced in doxorubicin plus CD47 mAb‐treated mice (P = 0.002) (Fig. 5A,B).